Therapy for Cystic Fibrosis

LUDER, E Gene TOPICS IN CLINICAL NUTRITION1999 SEP ;14(4):22-30

ABSTRACT: Cystic fibrosis (CF) is a common genetic disorder in the Caucasian population. The gen was identified in 1989 on chromosome 7. The encoded gene product, named cystic fibrosis transmembrane conductance regulator (CFTR), corresponds to a cyclic adenosine monophosphate (cAMP)-regulated chloride channel found almost exclusively in the secretory epithelial cells. Although the major mutation that results in a single amino acid deletion (AF508) accounts for 70% of the disease alleles, more than 700 additional mutant alleles of different forms have been detected. A good correlation has been found between CFTR genotype and one of the clinical variables-pancreatic function status. Much has been learned about the feasibility of gene therapy; however, there are substantial challenges ahead before gene therapy for CF can be considered a proven therapeutic option.

SOTO | USA > SOT Literature > Cystic Fibrosis > Therapy for Cystic Fibrosis

Editor Recommends
Most Read Articles

Editor Recommends

This SOT Literature Page and all its contents herein are published by SOTO-USA solely for the purpose of education. All rights reserved by SOTO-USA to accept, reject or modify any submission for publication. The opinions stated in the electronically printed material herein are those of the authors and do not necessarily represent the opinions of SOTO-USA or other individuals associated with SOTO-USA. SOTO-USA does not guarantee or make any representation that the printed material contained herein is valid, reliable or accurate. SOTO-USA does not assume any responsibility for injury arising from any use or misuse of the printed material herein. The printed material contained herein is assumed to be from reliable sources and there is no implication that the printed material herein present the only, or the best methodologies or procedures for the care or treatment of conditions discussed. It is incumbent upon the reader to verify the accuracy of any diagnosis and treatment information contained herein, and to make modifications as new information and/or research arises.